Sandoz's Somatropin Becomes First Biosimilar Approved In Japan
This article was originally published in The Pink Sheet Daily
Executive Summary
Japan's Ministry of Health, Labor and Welfare approved the recombinant human growth hormone injection less than a year after releasing draft guidelines and three months after Sandoz/Novartis submitted the application.